Novel direct and indirect cyclin-dependent kinase modulators for the prevention and treatment of human neoplasms.
about
Status of p53 in human cancer cells does not predict efficacy of CHK1 kinase inhibitors combined with chemotherapeutic agentsIdentification of a kinase profile that predicts chromosome damage induced by small molecule kinase inhibitorsCirculating MiR-125b as a marker predicting chemoresistance in breast cancerGene Expression Profiling of Primary Cutaneous Melanoma and Clinical OutcomeMarkers of tumor-initiating cells predict chemoresistance in breast cancer.Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma.Effects of an Indolocarbazole-Derived CDK4 Inhibitor on Breast Cancer CellsAnticancer Alkaloids from Trees: Development into Drugs.Targeting gonadotropins: an alternative option for Alzheimer disease treatment.Ethanol extract of Innotus obliquus (Chaga mushroom) induces G1 cell cycle arrest in HT-29 human colon cancer cells.SNS-032 prevents tumor cell-induced angiogenesis by inhibiting vascular endothelial growth factorCellular senescence and cancer chemotherapy resistance.Clinico-prognostic value of D-type cyclins and p27 in laryngeal cancer patients: a review.Changes in tight junctional resistance of the cervical epithelium are associated with modulation of content and phosphorylation of occludin 65-kilodalton and 50-kilodalton forms.DNA repair and cell cycle checkpoint defects as drivers and therapeutic targets in melanoma.Potential Use of Flavopiridol in Treatment of Chronic Diseases.Flavopiridol downregulates the expression of both the inducible NO synthase and p27(kip1) in malignant cells from B-cell chronic lymphocytic leukemia.Inhibition of polyamine oxidase prevented cyclin-dependent kinase inhibitor-induced apoptosis in HCT 116 colon carcinoma cells.A Review on Adducin from Functional to Pathological Mechanisms: Future Direction in Cancer.Metal Compounds as Kinase and Phosphatase Inhibitors in Drug Development: The Role of the Metal and Ligands
P2860
Q28291220-83084EBA-BE74-41D5-AF5C-D1449B492E71Q28475736-472454AB-5271-4C0C-B999-9C67D3431C73Q28482362-B278F344-B29C-4FF3-8817-94CC6C59F483Q29011337-C0CDC83A-02C9-4CE7-8265-A65D37417732Q33781163-62D35F8B-AC50-406C-A1BE-298951963448Q34163076-DCBA65EB-1F5E-46AC-A933-37FFB59EE7D0Q34487091-DD919B12-0008-4175-9E21-452022C78846Q34549113-BCCFE997-B822-49D4-B134-F3B2CA56D0D3Q35016901-D41F543B-3C75-4F78-B85B-6FF28274C116Q35308014-75610DB8-C869-46A3-A744-BE15005654C8Q35812724-2761403A-33B1-4810-8771-9C0D0CF37811Q35947022-DA04D16B-E3AE-47E7-A220-3FFF8223E08AQ36238230-A81F74F5-5D69-46A1-88B5-3A314B8C7A98Q36692784-03F4BFF6-6445-41A4-BE27-F10C1B6E1FEEQ38120311-F5426996-34C9-4D80-8953-F46F9E662468Q38988581-3202EB9A-6755-457C-B1BA-3EE424376A01Q44605542-AA8EC9E6-0989-4EA3-A819-B427889CD717Q45402754-B5B6D6A8-ED04-40C0-B108-D7A85A05DA60Q54977228-8FAC3FB7-AB7B-460D-9082-1B4DAB158645Q57693525-CE0266DD-B505-4E41-A2F5-7AF7C2B05A72
P2860
Novel direct and indirect cyclin-dependent kinase modulators for the prevention and treatment of human neoplasms.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Novel direct and indirect cycl ...... treatment of human neoplasms.
@ast
Novel direct and indirect cycl ...... treatment of human neoplasms.
@en
type
label
Novel direct and indirect cycl ...... treatment of human neoplasms.
@ast
Novel direct and indirect cycl ...... treatment of human neoplasms.
@en
prefLabel
Novel direct and indirect cycl ...... treatment of human neoplasms.
@ast
Novel direct and indirect cycl ...... treatment of human neoplasms.
@en
P1476
Novel direct and indirect cycl ...... treatment of human neoplasms.
@en
P2093
Adrian M Senderowicz
P2888
P304
P356
10.1007/S00280-003-0624-X
P478
52 Suppl 1
P577
2003-06-18T00:00:00Z